Hemodiafiltration and high-flux hemodialysis significantly reduce serum valproate levels inducing epileptic seizures: case report.
نویسندگان
چکیده
cally appearing after her HD sessions. At that time she was treated with postdilutional HDF, with 20 l infusate per 4.5-hour session, FX80 dialyzer (helixone, 1.8 m 2 , Fresenius Medical Care, Bad Homburg, Germany), blood flow 300 ml/min, AVF as vascular access. Valproate concentrations were measured before and after HDF approximately every 2 weeks and were 666 8 53 (range 567–750, therapeutic levels 345– 690) mol/l before and 341 8 63 (range 261–462) mol/l after HDF, which represents a 49 8 9% (range 38–59%) decrease Sir, Valproate is used in the treatment of some forms of epilepsy. A recent review of antiepileptic drugs in patients with kidney disease [1] reports that dose supplementation after hemodialysis (HD) is not routinely recommended. It refers to some rather old literature, reporting that (lowefficiency) dialysis removes only 20% of administered valproate dose [2] and that (low-efficiency) HD (combined with hemoperfusion) produces only a transient drop in valproate concentration [3] . A significant removal of valproate with (highefficiency) HD has been reported in recent years, but only in cases of valproate intoxication at serum concentrations up to 10 times therapeutic levels [4, 5] . The previously mentioned review therefore remarks that the effect of high-efficiency HD on clearance and seizure activity in patients on chronic HD is not known. We report a case of a 23-year-old female HD patient (dry weight 57 kg, primary renal disease focal segmental glomerulosclerosis) who has been on HD for 3 years. She has had epilepsy since the age of 5 years and was treated with entericcoated valproic acid (Apilepsin ) 1,500– 1,800 mg on the non-dialysis day, with an additional 150–300 mg on the dialysis day – taken before or during HD. As hemodiafiltration (HDF) was introduced in our center in 2006, she began to experience short partial complex seizures typiPublished online: June 4, 2008
منابع مشابه
Survival Benefit of Hemodiafiltration Compared With Prolonged High-flux Hemodialysis.
INTRODUCTION Patients on dialysis have a high rate of death, mainly of cardiovascular cause. Nephrologists are actively looking for ways to improve patients' outcomes, and alternative dialysis strategies, such as long conventional hemodialysis and hemodiafiltration, are currently being investigated. The aim of this study was to compare anemia, nutrition, inflammation, mineral metabolism, and 3...
متن کاملA comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study.
Some of the morbidity associated with chronic hemodialysis is thought to result from retention of large molecular weight solutes that are poorly removed by diffusion in conventional hemodialysis. Hemodiafiltration combines convective and diffusive solute removal in a single therapy. The hypothesis that hemodiafiltration provides better solute removal than high-flux hemodialysis was tested in a ...
متن کاملParameters of Hemodialysis Adequacy and Patients' Survival Depending on Treatment Modalities.
INTRODUCTION Retrospective studies showed that hemodiafiltration was associated with a reduced risk of mortality compared with standard hemodialysis in the patients with end-stage renal disease. Recently, a few prospective randomized clinical trials found no advantage in survival with hemodiafiltration as compared with high-flux hemodialysis and low-flux hemodialysis. The aim of this study was ...
متن کاملAntiepileptic drugs reduce serum uric acid.
Uric acid examination in 554 epileptic out-patients under long-term anticonvulsant medication revealed significantly lower serum concentrations compared to a group of normal controls. In patients taking enzyme-inducing drugs, uric acid levels were found to be lower than in those under valproate sodium. In addition, uric acid concentrations showed a negative correlation with duration of therapy ...
متن کاملNovel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
Multiple myeloma (MM) is a malignancy with excessive production of monoclonal proteins. At disease presentation 30% of MM patients have significant renal impairment which may progress to renal failure requiring dialysis. Besides chemotherapy extracorporeal elimination procedures such as plasma exchange have been applied as adjuvant strategies to eliminate free light chains from circulating bloo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood purification
دوره 26 4 شماره
صفحات -
تاریخ انتشار 2008